Abstract:Male androgenetic alopecia is a common condition and represents a major concern for patients who experience this condition. While there are different treatments to stop hair loss and improve hair density, the 5-alpha reductase inhibitors have demonstrated to be effective in improving androgenetic alopecia in men and can maintain a positive response for many years. Oral finasteride 1 mg is a US FDA-approved option, but dutasteride 0.5 mg has been proven to induce better responses, especially in the frontal area. Both have been shown to be safe in clinical trials but there is widespread concern about sexual adverse effects among patients. The use of topical finasteride has increased during the last few years as a useful option to avoid systemic therapy. The efficacy of topical finasteride 0.25% daily has been demonstrated in clinical trials, with a less marked decrease in serum dihydrotestosterone levels than with oral intake. Mesotherapy with dutasteride has also become more widespread recently, although evidence of its effectiveness is limited to retrospective studies in real clinical practice. The use of oral minoxidil in androgenetic alopecia has not been approved by the FDA, however several clinical studies have shown that it is an effective treatment option. The initial dose recommended to treat male hair loss is 2.5 mg daily, although the dose is frequently increased to 5 mg daily. The main adverse effect of oral minoxidil is hypertrichosis, followed by dizziness or lower limb edema, which are much less common. Platelet-rich plasma is a non-pharmacological option to treat male androgenetic alopecia, with some clinical trials demonstrating an improvement in hair count after several months. Among the published studies, the main limitation to compare its efficacy is the heterogeneity of the procedure. The most frequent regimens propose treatment every 4 weeks for 3 months initially to assess the individual response. Another treatment alternative is the use of light devices with wavelengths of between 630 and 660 nm, known as low-level laser therapy. These devices can be used at home every day for 15–30 min. Their efficacy has been shown in a limited number of clinical trials; however, there is a lack of evidence about the efficacy of these devices compared with other medical options or as a complementary therapy in hair loss. The pipeline of potential new treatments for male androgenetic alopecia is strong. Pyrilutamide and GT20029 are being studied as topical antagonists of the androgen receptor, while cetirizine is another topical option with some initial promising results. Furthermore, according to isolated studies with heterogeneous treatment schemes, the use of botulinum toxin in the scalp might improve androgenetic alopecia, and lastly, scalp threading might increase the total hair count as growth factors are released during implantation.

Cell Therapy for Androgenetic Alopecia: Elixir or Trick?

Serum Levels of Androgen-Associated Hormones Are Correlated with Curative Effect in Androgenic Alopecia in Young Men

Cell-free fat extract restores hair loss: a novel therapeutic strategy for androgenetic alopecia

Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics

The role of exosomes in follicle regeneration of androgenic alopecia

Current advances in stem cell-based therapies for hair regeneration

Androgenetic Alopecia: Therapy Update

Progress on the mechanism of natural products alleviating androgenetic alopecia

Treatment of Androgenetic Alopecia Using PRP to Target Dysregulated Mechanisms and Pathways

What's New in Therapy for Male Androgenetic Alopecia?

Medical Treatment for Androgenetic Alopecia

The Therapeutic Progress of Androgenetic Alopecia

Clinical and preclinical approach in AGA treatment: a review of current and new therapies in the regenerative field

Updated Review of Treatment of Androgenetic Alopecia

Advances in Regenerative Stem Cell Therapy in Androgenic Alopecia and Hair Loss: Wnt Pathway, Growth-Factor, and Mesenchymal Stem Cell Signaling Impact Analysis on Cell Growth and Hair Follicle Development

Dutasteride for the Treatment of Androgenetic Alopecia: An Updated Review

Favorable effect of herbal extract on androgenic alopecia: A case report

Treatment of Alopecia by Transplantation of Hair Follicle Stem Cells and Dermal Papilla Cells Encapsulated in Alginate Gels

Treatment of androgenetic alopecia by exosomes secreted from hair papilla cells and the intervention effect of LTF

Enhancing Quality of Life and Sexual Functioning in Female Androgenetic Alopecia: Therapeutic Potential of Hair Follicle-Derived Stem Cells